BI

Bhavik Indravadan Presswala

Active Director Director DIN 11680443
DIN 11680443 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhavik Indravadan Presswala

Data last updated:

Bhavik Indravadan Presswala is a Director at Velmora Pharmaceutical Private Limited (since 2026) and Director at Globherb Wellness Private Limited (since 2026).

DIN 11680443
Primary Designation Director
First Appointment 22 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20262026Active
Globherb Wellness Private Limited U21001GJ2026PTC176920
Director22 Apr 20262026Active

Board colleagues of Bhavik Indravadan Presswala

Directorship timeline

Open interactive timeline →
Globherb Wellness Private Limited
Velmora Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bhavik Indravadan Presswala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhavik Indravadan Presswala

Bhavik Indravadan Presswala currently holds 2 directorships: Velmora Pharmaceutical Private Limited (Director, since 17 Sep 2026); Globherb Wellness Private Limited (Director, since 22 Apr 2026).

Bhavik Indravadan Presswala was first appointed on 22 Apr 2026 as Director at Globherb Wellness Private Limited.

The current boards of Bhavik Indravadan Presswala's companies include Bhoya Nigeshbhai Naginbhai (Velmora Pharmaceutical Private Limited), Dharmeshbhai Prahladbhai Shukla (Globherb Wellness Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available